In a Rough Spot For Stocks, BTAL Lives up to Its Billing

These are volatile times for equities due to the COVID-19 epidemic, but the AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is doing exactly what it’s supposed to do: providing investors with shelter from the storm while delivering upside against a challenging backdrop. Additionally, BTAL can...